This site has now been archived and content is not being updated. |
You are here
COVID-19 Global Rheumatology Alliance Study
COVID-19 Research Area(s): Healthcare Delivery & Policy
There is an urgent public health need to understand how the medications used to treat rheumatic diseases affect COVID-19 treatments and responses. This is a global rheumatologist study to understand how rheumatic auto-immune diseases and the medications used to treat them affect COVID-19 infections, treatment and outcomes.
Post date:
Apr 21, 2020